Large-scale testing (Phase 3)Study completedNCT01953328
What this trial is testing
Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk
Who this might be right for
Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events
Amgen 409